Evidence map›Paper›PMID 31763533›Full record

ArticleACS omega2019

Nitrone-Modified Gold Nanoparticles: Synthesis, Characterization, and Their Potential as

Sara Ghiassian, Lihai Yu, Pierangelo Gobbo, Ali Nazemi, Tommaso Romagnoli, Wilson Luo, Leonard G Luyt, Mark S Workentin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. [Molecules (Basel, Switzerland) · 2024
    Review
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sara GhiassianDepartment of Chemistry and the Center for Materials and Biomaterials Research and Department of Oncology, The University of Western Ontario, London N6A 5B7, Ontario, Canada.
Lihai YuLondon Regional Cancer Program, 800 Commissioners Rd. E., London N6A 5W9, Ontario, Canada.
Pierangelo GobboDepartment of Chemistry and the Center for Materials and Biomaterials Research and Department of Oncology, The University of Western Ontario, London N6A 5B7, Ontario, Canada.
Ali NazemiDepartment of Chemistry and the Center for Materials and Biomaterials Research and Department of Oncology, The University of Western Ontario, London N6A 5B7, Ontario, Canada.
Tommaso RomagnoliDepartment of Chemistry and the Center for Materials and Biomaterials Research and Department of Oncology, The University of Western Ontario, London N6A 5B7, Ontario, Canada.
Wilson LuoDepartment of Chemistry and the Center for Materials and Biomaterials Research and Department of Oncology, The University of Western Ontario, London N6A 5B7, Ontario, Canada.
Leonard G LuytDepartment of Chemistry and the Center for Materials and Biomaterials Research and Department of Oncology, The University of Western Ontario, London N6A 5B7, Ontario, Canada.
Mark S WorkentinDepartment of Chemistry and the Center for Materials and Biomaterials Research and Department of Oncology, The University of Western Ontario, London N6A 5B7, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel bioorthogonal gold nanoparticle (AuNP) template displaying interfacial nitrone functional groups for bioorthogonal interfacial strain-promoted alkyne-nitrone cycloaddition reactions has been synthesized. These nitrone-AuNPs were characterized in detail using

Identifiers

PMID31763533
PMCPMC6868604

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.